Evaluating the Lower Urinary Tract Syndrome with a Telemedicine Application: An Exploration of the Electronic Audiovisual Prostate Symptom Score.
audiovisual symptom scale
benign prostatic hyperplasia (BPH)
electronic symptom assessment
lower urinary tract symptoms (LUTS)
telemedicine application
Journal
Frontiers in surgery
ISSN: 2296-875X
Titre abrégé: Front Surg
Pays: Switzerland
ID NLM: 101645127
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
01
2022
accepted:
06
04
2022
entrez:
25
8
2022
pubmed:
26
8
2022
medline:
26
8
2022
Statut:
epublish
Résumé
The Visual Prostate Symptom Score (VPSS) is used for the assessment of lower urinary tract symptoms (LUTS). It is usually administered by general practitioners (GPs), but in these cases, outcomes do not seem to be reflecting the real conditions of a patient well, with consequent risks of misestimations and misinterpretations. We developed an electronic audiovisual version of VPSS (EPSS), a new symptom scale based on a telemedicine mobile light-based app. The aim of this study is to test and evaluate its reliability. We enrolled male patients aged between 50 and 80 years across 24 community-based healthcare facilities in Guangzhou, China. Patients were asked to complete the Chinese version of VPSS and EPSS before consultation with the urology specialists. Patients were divided into two groups based on age. First, we analyzed the rate of full understanding of EPSS using a chi-square test. Then, we analyzed the difference between each score of EPSS, VPSS, and outcomes measured by specialists, used as the reference score (RS). Finally, the outcomes were analyzed with the Spearman test and Bartlett test separately. Seventy-nine male patients were included (mean age 70.42 years). Patients were divided into two groups: group 1 (>70 years, EPSS can be easily used in a significant number of patients and showed correlation with the VPSS and RS. Moreover, certain items resulted in better performance than VPSS. The results showed that EPSS could be a valuable option for both patients and GPs monitoring LUTS and particularly helpful when teleconsultations are considered, especially during the COVID-19 pandemic.
Sections du résumé
Background
UNASSIGNED
The Visual Prostate Symptom Score (VPSS) is used for the assessment of lower urinary tract symptoms (LUTS). It is usually administered by general practitioners (GPs), but in these cases, outcomes do not seem to be reflecting the real conditions of a patient well, with consequent risks of misestimations and misinterpretations. We developed an electronic audiovisual version of VPSS (EPSS), a new symptom scale based on a telemedicine mobile light-based app. The aim of this study is to test and evaluate its reliability.
Methods
UNASSIGNED
We enrolled male patients aged between 50 and 80 years across 24 community-based healthcare facilities in Guangzhou, China. Patients were asked to complete the Chinese version of VPSS and EPSS before consultation with the urology specialists. Patients were divided into two groups based on age. First, we analyzed the rate of full understanding of EPSS using a chi-square test. Then, we analyzed the difference between each score of EPSS, VPSS, and outcomes measured by specialists, used as the reference score (RS). Finally, the outcomes were analyzed with the Spearman test and Bartlett test separately.
Results
UNASSIGNED
Seventy-nine male patients were included (mean age 70.42 years). Patients were divided into two groups: group 1 (>70 years,
Conclusion
UNASSIGNED
EPSS can be easily used in a significant number of patients and showed correlation with the VPSS and RS. Moreover, certain items resulted in better performance than VPSS. The results showed that EPSS could be a valuable option for both patients and GPs monitoring LUTS and particularly helpful when teleconsultations are considered, especially during the COVID-19 pandemic.
Identifiants
pubmed: 36003282
doi: 10.3389/fsurg.2022.848923
pmc: PMC9394459
doi:
Types de publication
Journal Article
Langues
eng
Pagination
848923Informations de copyright
Copyright © 2022 Liu, Guan, Lan, zhao, Ye, Lv, Yu, Wang, Peng, Fu, Mazzon and GU.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Low Urin Tract Symptoms. 2022 Mar;14(2):92-101
pubmed: 34734477
Health Qual Life Outcomes. 2014 Jan 02;12:1
pubmed: 24382363
J Urol. 2021 Oct;206(4):806-817
pubmed: 34384237
Eur Urol. 2015 Jun;67(6):1099-1109
pubmed: 25613154
J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1993-1998
pubmed: 29729101
Med Clin North Am. 2018 Mar;102(2):387-398
pubmed: 29406066
Eur Urol. 2021 Feb;79(2):243-262
pubmed: 33172724
J Urol. 2017 Feb;197(2S):S189-S197
pubmed: 28012747
Pediatr Res. 2021 Aug;90(2):411-418
pubmed: 33203966
Prog Urol. 2003 Dec;13(6):1286-9
pubmed: 15000300
Stud Health Technol Inform. 2011;163:425-7
pubmed: 21335833
Gerontologist. 2021 Jul 13;61(5):693-702
pubmed: 32744310
J Telemed Telecare. 2014 Dec;20(8):427-30
pubmed: 25316038
J Med Internet Res. 2020 May 8;22(5):e19577
pubmed: 32349962
Nat Rev Urol. 2011 Sep 20;8(10):536-7
pubmed: 21931343
Health Informatics J. 2020 Mar;26(1):233-247
pubmed: 30672358
Urology. 1997 Jan;49(1):46-9
pubmed: 9000184
Urology. 2011 Jul;78(1):17-20
pubmed: 21550646